Eterna Therapeutics Inc (NASDAQ:ERNA) currently has a daily average trading volume of 10.79M but it saw 12557258 shares traded in last market. With a market cap of 32.63M USD, the company’s current market price of $0.64 came rising about 35.44 while comparing to the previous closing price of $0.47. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.62 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.4411 while lowest mark touched by it was $0.738.
Taking a look at 20-day trading activity of Eterna Therapeutics Inc (ERNA) gives us an average price of $0.3516, while its current price level is -75.81% below from 52-week high level whereas it is 187.12% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4690 while that of 200 days or SMA-200 reads an average of $1.3900. A closer look into the stock’s movement over the week reveals that its volatility is standing at 35.29% during that period while stretching the period over a month that decreases to 26.50%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 71.07 which implies that the stock is in overbought territory.
Over the week, ERNA’s stock price is moving 38.67% up while it is 135.22% when we observe its performance for the past one month. Year-to-date it is 116.02% up and over the past year, the stock is showing a downside performance of -54.31%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Eterna Therapeutics Inc’s total number of outstanding shares is 51.37M with 336.35% of that held by the insiders while 11.00% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1154.18%. Stock’s beta reads 4.37. Stock has a price to sale or P/S ratio amounts to 54.38. Its return on asset (ROA) is -149.86% on average.
